www.pengnuochemical.com
Shijiazhuang PengNuo Technology Co., Ltd
Recently, U.S. President Trump announced the imposition of tariffs of up to 200% on imported pharmaceuticals, with an 18-month transition period. This policy directly impacts the global pharmaceutical network centered in Ireland—the country’s annual pharmaceutical output is nearly €100 billion, with top companies like Pfizer and Eli Lilly operating factories there. Exports to the U.S. account for 38% of Ireland’s total exports. Currently, giants such as Lilly and Johnson & Johnson have announced plans to invest over $80 billion in building factories in the U.S. over the next five years.
Accelerated Reshaping of the Global Manufacturing Landscape
Europe’s Response: Ireland is mitigating risks by expanding exports, with pharmaceutical exports to the U.S. surging by 130% in Q1 2025.
China’s Challenge: Multinational companies are rapidly relocating production capacity to Southeast Asia, with Vietnam seeing a more than 300% increase in textile and electronics orders transferred from China.
Cost Dilemma: China’s manufacturing wages have reached 30% of U.S. levels, with the labor cost advantage continuing to weaken.
Three Breakthroughs for “Smart Manufacturing” in China
Technological Advancement: Enhance competitiveness through innovation.
Market Diversification: For export businesses, explore new regions and markets.
Intelligent Transformation: Accelerate smart production to reduce costs.
Corporate Action Declaration
We will seize the window of opportunity in the global supply chain restructuring, gradually increase R&D investment over the next three years, and enhance risk resilience through the development of digital supply chains.
Our products include：
1,4-Dimethoxybenzene CAS： 150-78-7
Dimethoxybenzene CAS： 151-10-0
4-Morpholineethanesulfonic acid CAS： 4432-31-9
3-Nitrobenzaldehyde CAS： 99-61-6
3-Nitrobenzoic acid CAS： 121-92-6
Post time: Jul-16-2025